WILLIAM K. SUMMERS, M.D. graduated from Washington University School of Medicine (St. Louis) in 1971, and trained in both Internal Medicine and Neuropsychiatry at Washington University. He has been on the faculty of the University of Pittsburgh, the University of Southern California, and the University of California Los Angeles. Dr. Summers has been in private medical practice since 1981, but has continued in academic pursuits. His 1986 benchmark publication in The New England Journal of Medicine on the use of tacrine (Cognex®) to treat Alzheimer’s disease revolutionized the field.
At the time it was thought impossible to treat Alzheimer’s disease. As is typical of unexpected innovation, he was subjected to intense FDA investigation. No improper conduct or research reporting was discovered. Ten critical editorials in The Wall Street Journal followed this FDA investigation. In 1989, the FDA declared a ‘mutual consent decree’ to the public. Today, there are five drugs in the antidementia field, with four of these based on Dr. Summers’ original hypothesis. Characteristic of autocratic bureaucracies, the FDA put Dr. Summers on a secret black list, which was removed after its discovery in 2006.
Dr. Summers has numerous awards, and is an international speaker. He has forty-eight papers in major medical journals. He has earned eight U.S. and international patents in pharmacology and health supplements. He is the inventor of Memory reVITALIZER®, a 35-component full-spectrum antioxidant blend which is derived from his revolutionary peer reviewed paper on the cause and prevention of Alzheimer’s disease (Journal of Alzheimer’s Disease, 2004; 6:651-657).
In 1999, Dr. Summers founded the Alzheimer’s Corporation located in Albuquerque, New Mexico, which features innovative dementia care, anti-aging medicine and markets Memory reVITALIZER®.
He may be contacted by phone 800-606-0192, fax 505-888-6000, website www.ALZcorp.com
and e-mail info@ALZcorp.com.
Dr. Summers will speak on Help For Memory Problems & Alzheimer’s Disease.